Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Defining High Risk Myeloma Using Co-Segregating FISH Variables; Results of MRC Myeloma IX

Kevin D Boyd, MBBS, Fiona M. Ross, PhD, William J Tapper, PhD, Laura Chiecchio, PhD, GianPaolo Dagrada, Rebecca Protheroe, David Stockley, Zoe Konn, Walter M Gregory, PhD, Brian A Walker, PhD, Christopher P Wardell, PhD, Faith E Davies, MD, Gareth J Morgan, MD, PhD

Blood (2010) 116 (21): 1907.

https://doi.org/10.1182/blood.V116.21.1907.1907

Published: 2010

Journal Articles

Thalidomide Maintenance Significantly Improves Progression-Free Survival (PFS) and Overall Survival (OS) of Myeloma Patients When Effective Relapse Treatments Are Used: MRC Myeloma IX Results

Gareth J Morgan, MD, PhD, Faith E. Davies, MD, Walter M. Gregory, PhD, Sue E. Bell, PhD, Alex J. Szubert, MSc, Nuria Navarro-Coy, MPhil, Mark T. Drayson, MD, PhD, Roger G. Owen, MD, Gordon Cook, MD, Fiona M. Ross, PhD, Graham H. Jackson, MD, J. Anthony Child, MD

Blood (2010) 116 (21): 623.

https://doi.org/10.1182/blood.V116.21.623.623

Published: 2010

Journal Articles

Integration of Gene Mapping and Expression Arrays Identifies Mechanisms by Which Genes Are Dysregulated as a Result of Copy Number Loss and Gain Associated with IgH Translocations in Multiple Myeloma.

Matthew W. Jenner, MD, Gonzalez David, PhD, Paola E. Leone, PhD, Brian A. Walker, PhD, David C. Johnson, BSc, Nicholas J. Dickens, PhD, Fiona M. Ross, PhD, Faith E. Davies, MD, Gareth J. Morgan, MD, PhD

Blood (2007) 110 (11): 395.

https://doi.org/10.1182/blood.V110.11.395.395

Published: 2007

Journal Articles

An Integrated Pharmacogenomic Strategy for the Definition of Thalidomide Response Signatures in Presenting Cases of Multiple Myeloma.

Gareth J. Morgan, MD, PhD, Matthew W. Jenner, MD, Brian A. Walker, PhD, David C. Johnson, BSc, Paola A. Leone, PhD, Fiona M. Ross, PhD, Mark T. Drayson, MD, PhD, Brian G. Van Ness, Brian G. Durie, Nicholas J. Dickens, PhD, J. Anthony Child, R.G. Owen, Faith E. Davies, MD

Blood (2007) 110 (11): 2493.

https://doi.org/10.1182/blood.V110.11.2493.2493

Published: 2007

Journal Articles

Multiple Myeloma with IGH-Involving del(14q): Report of 34 Cases.

Iwona Wlodarska, PhD, Fiona M. Ross, PhD, Lisa J. Russell, PhD, Helena Pospisilova, Laura Chiecchio, Marie-Astrid Van Caillie, MD, GianPaolo Dagrada, Christiane De Wolf-Peeters, MD, PhD, Christine J. Harrison, PhD, Pascale De Paepe, MD, PhD, Peter Vandenberghe, MD, PhD, Lucienne Michaux, MD, PhD

Blood (2007) 110 (11): 991.

https://doi.org/10.1182/blood.V110.11.991.991

Published: 2007

Journal Articles

Sub-Classification of Hyperdiploid Myeloma Using Global Gene Expression Profiling and SNP-Based Mapping Arrays.

Brian A. Walker, PhD, Paola E. Leone, PhD, Matthew W. Jenner, MD, David C. Johnson, BSc, David Gonzalez, PhD, Mark T. Drayson, PhD, Fiona M. Ross, PhD, Faith E. Davies, MD, Gareth J. Morgan, MD PhD

Blood (2006) 108 (11): 3390.

https://doi.org/10.1182/blood.V108.11.3390.3390

Published: 2006

Journal Articles

Abnormalities of 16q in Multiple Myeloma Are Associated with Poor Prognosis: 500K Gene Mapping and Expression Correlations Identify Two Potential Tumor Suppressor Genes, WWOX and CYLD .

Matthew W. Jenner, MD, Paola E. Leone, PhD, Brian A. Walker, PhD, David C. Johnson, BSc, Laura Chiecchio, MSc, Elisabet Dachs Cabanas, BSc, Gian Paolo Dagrada, MSc, Mathew Nightingale, Rebecca K.M. Protheroe, BSc, David Stockley, BSc, Monica Else, MSc, Fiona M. Ross, PhD, Nicholas C.P. Cross, PhD, Faith E. Davies, MD, Gareth J. Morgan, MD, PhD

Blood (2006) 108 (11): 110.

https://doi.org/10.1182/blood.V108.11.110.110

Published: 2006

Journal Articles

Fine Mapping and Expression Analysis of Chromosome 1 with the Aim of Defining Critically Deregulated Genes Important in the Pathogenesis of Myeloma.

Paola E. Leone, PhD, Matthew W. Jenner, MD, Brian A. Walker, PhD, David C. Johnson, BSc, David Gonzalez, PhD, Fiona M. Ross, PhD, Faith E. Davies, MD, Gareth J. Morgan, MD, PhD

Blood (2006) 108 (11): 112.

https://doi.org/10.1182/blood.V108.11.112.112

Published: 2006

Journal Articles

Status of Chromosome 13 in Multiple Myeloma: Integrated Approach Using SNP Mapping Array and Gene Expression Array.

Paola E. Leone, PhD, Brian A. Walker, PhD, David Gonzalez, PhD, Matthew Jenner, MD, Fiona M. Ross, PhD, Cheng Li, PhD, Faith E. Davies, MD, Gareth J. Morgan, MD, PhD

Blood (2005) 106 (11): 1563.

https://doi.org/10.1182/blood.V106.11.1563.1563

Published: 2005

Journal Articles

Identification of Collaborating Oncogeneic Events Leading to Disease Progression in Myeloma Cases with a t(4;14) and t(11;14) Using SNP and Gene Expression Arrays.

Matthew W. Jenner, MD, Brian A. Walker, PhD, Paola E. Leone, PhD, David Gonzalez, PhD, Fiona M. Ross, PhD, Cheng Li, PhD, Faith E. Davies, MD, Gareth J. Morgan, PhD

Blood (2005) 106 (11): 1542.

https://doi.org/10.1182/blood.V106.11.1542.1542

Published: 2005

Journal Articles

Insights into the Basis of Chromosomal Imbalances during the Clonal Evolution of Multiple Myeloma Using SNP Array Analysis.

Brian A. Walker, PhD, Paola E. Leone, PhD, Matthew Jenner, MD, David Gonzalez, PhD, Fiona M. Ross, PhD, Cheng Li, PhD, Faith E. Davies, MD, Gareth J. Morgan, MD, PhD

Blood (2005) 106 (11): 621.

https://doi.org/10.1182/blood.V106.11.621.621

Published: 2005

NARROW

Defining High Risk Myeloma Using Co-Segregating FISH Variables; Results of MRC Myeloma IX

Thalidomide Maintenance Significantly Improves Progression-Free Survival (PFS) and Overall Survival (OS) of Myeloma Patients When Effective Relapse Treatments Are Used: MRC Myeloma IX Results

Integration of Gene Mapping and Expression Arrays Identifies Mechanisms by Which Genes Are Dysregulated as a Result of Copy Number Loss and Gain Associated with IgH Translocations in Multiple Myeloma.

An Integrated Pharmacogenomic Strategy for the Definition of Thalidomide Response Signatures in Presenting Cases of Multiple Myeloma.

Multiple Myeloma with IGH-Involving del(14q): Report of 34 Cases.

Sub-Classification of Hyperdiploid Myeloma Using Global Gene Expression Profiling and SNP-Based Mapping Arrays.

Abnormalities of 16q in Multiple Myeloma Are Associated with Poor Prognosis: 500K Gene Mapping and Expression Correlations Identify Two Potential Tumor Suppressor Genes, WWOX and CYLD .

Fine Mapping and Expression Analysis of Chromosome 1 with the Aim of Defining Critically Deregulated Genes Important in the Pathogenesis of Myeloma.

Status of Chromosome 13 in Multiple Myeloma: Integrated Approach Using SNP Mapping Array and Gene Expression Array.

Identification of Collaborating Oncogeneic Events Leading to Disease Progression in Myeloma Cases with a t(4;14) and t(11;14) Using SNP and Gene Expression Arrays.

Insights into the Basis of Chromosomal Imbalances during the Clonal Evolution of Multiple Myeloma Using SNP Array Analysis.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only